# A Study of Once-Monthly Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia.

> **NCT00560547** · PHASE3 · WITHDRAWN · sponsor: **Hoffmann-La Roche**

## Conditions studied

- Anemia

## Interventions

- **DRUG:** methoxy polyethylene glycol-epoetin beta

## Key facts

- **NCT ID:** NCT00560547
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-10
- **Primary completion:** —
- **Final completion:** 2009-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study was cancelled before any patients were enrolled, due to operational reasons.
- **Last updated:** 2016-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00560547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00560547, "A Study of Once-Monthly Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00560547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*